Shandong Buchang Pharmaceuticals has received the drug registration certificate for the suspension of Oseltamivir Phosphate.

09/01/2025

GMT Eight

Shandong Buchang Pharmaceuticals (603858.SH) announced that its wholly-owned subsidiary, Baoding Tianhao Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the suspension of Oseltamivir Phosphate.

Hunan SUND Technological Corporation (301548.SZ) Special Dividend Equity Distribution for the year 2024: RMB 2.80 per 10 shares.

GF Securities: 25-year policy implementation expected to continue boosting domestic demand for household appliances.

Contact: contact@gmteight.com

Shandong Buchang Pharmaceuticals has received the drug registration certificate for the suspension of Oseltamivir Phosphate.

RECOMMEND

American Economy: Stagflation or Recession?

Ping An Securities: Economic "stagflation" expectations are warming up, coupled with downward revisions in performance expectations. There is still pressure for further correction in the US stock market.

China Securities Co., Ltd.: The mid-term trend of revaluation of Chinese assets confidence is expected to continue. The technology growth sector is still the main driver in the mid-term.